|
Showing the most relevant articles for your search:NASDAQ:AFFX | Date | Time | Source | Headline | Symbol | Company | | 06/14/2011 | 6:15AM | Business Wire | Affymetrix Expands the Expression Power of the GeneAtlas® Personal Microarray System | NASDAQ:AFFX | Affymetrix, Inc. |
| 06/13/2011 | 10:04AM | Zacks | Luminex in E. coli Management - Analyst Blog | NASDAQ:AFFX | Affymetrix, Inc. |
| 06/06/2011 | 6:40PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AFFX | Affymetrix, Inc. |
| 06/03/2011 | 12:19PM | Zacks | Luminex, LIFE in MAGPIX Pact - Analyst Blog | NASDAQ:AFFX | Affymetrix, Inc. |
| 06/03/2011 | 5:10AM | Zacks | Company News for June 03, 2011 - Corporate Summary | NASDAQ:AFFX | Affymetrix, Inc. |
| 06/02/2011 | 6:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AFFX | Affymetrix, Inc. |
| 06/02/2011 | 6:01AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AFFX | Affymetrix, Inc. |
| 06/01/2011 | 9:00AM | Business Wire | Affymetrix Appoints Frank Witney, Ph.D., as President and Chief Executive Officer | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/27/2011 | 6:15AM | Business Wire | Affymetrix Selects BioDiscovery as OncoScan™ FFPE Express Preferred Software Provider | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/19/2011 | 5:50AM | Business Wire | Affymetrix Adds New Tools for Targeted Genotyping Market to Accelerate Disease Studies | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/18/2011 | 11:52AM | Zacks | Neutral on Affymetrix - Analyst Blog | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/18/2011 | 6:05AM | Business Wire | Affymetrix Releases New Applied Research Arrays Designed with Scientific Leaders | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/13/2011 | 2:27PM | Zacks | Luminex Stays at Neutral - Analyst Blog | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/10/2011 | 8:00AM | Zacks | Luminex Tops Ests, Profit Cruises - Analyst Blog | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/09/2011 | 6:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/09/2011 | 6:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/09/2011 | 6:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/09/2011 | 6:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/09/2011 | 6:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/09/2011 | 6:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/09/2011 | 6:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/09/2011 | 5:25PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/09/2011 | 9:34AM | Dow Jones News | Affymetrix Gene-Expression Reagents Win FDA Clearance; Shares Up | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/09/2011 | 5:45AM | Business Wire | Affymetrix Achieves First FDA Clearance of Microarray-Based Gene Profiling Reagents | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/05/2011 | 6:00AM | Business Wire | Affymetrix to Webcast Annual Meeting of Shareholders | NASDAQ:AFFX | Affymetrix, Inc. |
| 05/02/2011 | 4:00PM | Business Wire | Affymetrix to Webcast Presentations from May Financial Conferences | NASDAQ:AFFX | Affymetrix, Inc. |
| 04/29/2011 | 2:23PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AFFX | Affymetrix, Inc. |
| 04/28/2011 | 3:03PM | Zacks | Affymetrix Profits, Misses Sales - Analyst Blog | NASDAQ:AFFX | Affymetrix, Inc. |
| 04/27/2011 | 4:04PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AFFX | Affymetrix, Inc. |
| 04/27/2011 | 4:00PM | Business Wire | Affymetrix Reports First Quarter Results | NASDAQ:AFFX | Affymetrix, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:AFFX |
|